As of 2024-12-13, the Relative Valuation of Microbix Biosystems Inc (MBX.TO) is 0.22 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.35 CAD, the upside of Microbix Biosystems Inc based on Relative Valuation is -36.6%.
The range of the Relative Valuation is 0.15 - 0.27 CAD.
| Range | Selected | |
| Trailing P/E multiples | 6.3x - 7.3x | 6.8x |
| Forward P/E multiples | 34.2x - 48.8x | 41.5x |
| Fair Price | 0.15 - 0.27 | 0.22 |
| Upside | -56.3% - -20.9% | -36.6% |
| Date | P/E |
| 2024-12-12 | 9.48 |
| 2024-12-11 | 9.21 |
| 2024-12-10 | 9.48 |
| 2024-12-09 | 9.34 |
| 2024-12-06 | 8.67 |
| 2024-12-05 | 8.81 |
| 2024-12-04 | 8.81 |
| 2024-12-03 | 8.81 |
| 2024-12-02 | 8.01 |
| 2024-11-29 | 8.14 |
| 2024-11-28 | 8.27 |
| 2024-11-27 | 8.41 |
| 2024-11-26 | 8.27 |
| 2024-11-25 | 8.27 |
| 2024-11-22 | 8.01 |
| 2024-11-21 | 8.01 |
| 2024-11-20 | 8.27 |
| 2024-11-19 | 8.41 |
| 2024-11-18 | 8.54 |
| 2024-11-15 | 8.41 |
| 2024-11-14 | 8.41 |
| 2024-11-13 | 8.27 |
| 2024-11-12 | 8.41 |
| 2024-11-11 | 8.41 |
| 2024-11-08 | 8.54 |
| 2024-11-07 | 8.41 |
| 2024-11-06 | 8.41 |
| 2024-11-05 | 8.41 |
| 2024-11-04 | 8.41 |
| 2024-11-01 | 8.54 |
| 2024-10-31 | 8.54 |
| 2024-10-30 | 8.41 |
| 2024-10-29 | 8.67 |
| 2024-10-28 | 8.67 |
| 2024-10-25 | 8.67 |
| 2024-10-24 | 8.81 |
| 2024-10-23 | 8.81 |
| 2024-10-22 | 9.07 |
| 2024-10-21 | 8.81 |
| 2024-10-18 | 8.94 |
| 2024-10-17 | 8.94 |
| 2024-10-16 | 8.94 |
| 2024-10-15 | 8.94 |
| 2024-10-11 | 8.94 |
| 2024-10-10 | 9.07 |
| 2024-10-09 | 9.21 |
| 2024-10-08 | 9.07 |
| 2024-10-07 | 8.94 |
| 2024-10-04 | 9.34 |
| 2024-10-03 | 9.48 |